Abstract
Single nucleotide polymorphisms in human MMP genes, including MMP1 (-1637 1G>2G), MMP3 (-1612 5A>6A), MMP9 (-1562 C>T), and MMP12 (-82 A>G), and their impact on multiple sclerosis risk and disease progression in a Polish population were investigated. Increased risk of MS was found among carriers of at least one T allele of MMP9 -1562 C>T (OR, 1.7; p=0.0030) and one G allele of MMP12 -82 A>G (OR, 3.9; p<0.00001). Additionally, an association between MMP9 genotype and MMP-9 levels in peripheral blood was detected. Our results suggest that MMP9 -1562 C>T and MMP12 -82 A>G polymorphisms affect susceptibility to multiple sclerosis.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Female
-
Genetic Predisposition to Disease
-
Genotype
-
Humans
-
Male
-
Matrix Metalloproteinase 1 / genetics*
-
Matrix Metalloproteinase 12 / genetics*
-
Matrix Metalloproteinase 3 / genetics*
-
Matrix Metalloproteinase 9 / genetics*
-
Middle Aged
-
Multiple Sclerosis / enzymology*
-
Multiple Sclerosis / epidemiology
-
Multiple Sclerosis / genetics*
-
Poland / epidemiology
-
Polymorphism, Single Nucleotide*
-
Risk Assessment
-
Risk Factors
-
Sex Factors
Substances
-
MMP3 protein, human
-
Matrix Metalloproteinase 3
-
Matrix Metalloproteinase 9
-
Matrix Metalloproteinase 12
-
MMP1 protein, human
-
Matrix Metalloproteinase 1